comparemela.com
Latest Breaking News On - Us81749d1072 - Page 1 : comparemela.com
Sera Prognostics Shares More Than Double on Study Efficacy
By Denny Jacob Sera Prognostics shares more than doubled following news of study efficacy being met. The stock surged to $5.24 in early trading, vs..
Denny-jacob
Data-safety-monitoring-board
Prematurity-risk-assessment-combined
Clinical-interventions
Improved-neonatal-outcomes
Article-normal
Biotechnology-services
Healthcare-life-sciences
Synd
Sera-prognostics
Sera
vimarsana © 2020. All Rights Reserved.